158 related articles for article (PubMed ID: 33058852)
21. Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells.
Amisten S; Mohammad Al-Amily I; Soni A; Hawkes R; Atanes P; Persaud SJ; Rorsman P; Salehi A
Endocr J; 2017 Mar; 64(3):325-338. PubMed ID: 28228611
[TBL] [Abstract][Full Text] [Related]
22. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
[TBL] [Abstract][Full Text] [Related]
23. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
[TBL] [Abstract][Full Text] [Related]
24. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
[TBL] [Abstract][Full Text] [Related]
25. CD33
Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
[TBL] [Abstract][Full Text] [Related]
26. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
[TBL] [Abstract][Full Text] [Related]
27. C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice.
Chu PS; Nakamoto N; Ebinuma H; Usui S; Saeki K; Matsumoto A; Mikami Y; Sugiyama K; Tomita K; Kanai T; Saito H; Hibi T
Hepatology; 2013 Jul; 58(1):337-50. PubMed ID: 23460364
[TBL] [Abstract][Full Text] [Related]
28. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria.
Wurbel MA; Malissen M; Guy-Grand D; Malissen B; Campbell JJ
J Immunol; 2007 Jun; 178(12):7598-606. PubMed ID: 17548595
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
[TBL] [Abstract][Full Text] [Related]
30. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
[TBL] [Abstract][Full Text] [Related]
31. CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist.
Lee S; Heinrich EL; Li L; Lu J; Choi AH; Levy RA; Wagner JE; Yip ML; Vaidehi N; Kim J
Mol Oncol; 2015 Oct; 9(8):1599-611. PubMed ID: 26003048
[TBL] [Abstract][Full Text] [Related]
32. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.
Rivera-Nieves J; Ho J; Bamias G; Ivashkina N; Ley K; Oppermann M; Cominelli F
Gastroenterology; 2006 Nov; 131(5):1518-29. PubMed ID: 17101325
[TBL] [Abstract][Full Text] [Related]
33. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum.
Ullah M; Eucker J; Sittinger M; Ringe J
Stem Cell Res Ther; 2013 Aug; 4(4):99. PubMed ID: 23958031
[TBL] [Abstract][Full Text] [Related]
35. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Zhang Y; Han J; Wu M; Xu L; Wang Y; Yuan W; Hua F; Fan H; Dong F; Qu X; Yao R
J Neuroimmune Pharmacol; 2019 Sep; 14(3):493-502. PubMed ID: 31065973
[TBL] [Abstract][Full Text] [Related]
36. Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.
Uehara S; Song K; Farber JM; Love PE
J Immunol; 2002 Jan; 168(1):134-42. PubMed ID: 11751956
[TBL] [Abstract][Full Text] [Related]
37. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo.
Tereshchenko V; Bulygin A; Zavodskii R; Maksyutov A; Kurilin V; Fisher M; Semenyuk N; Aladev S; Sennikov S
Cytokine; 2021 Jun; 142():155473. PubMed ID: 33647585
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
[TBL] [Abstract][Full Text] [Related]
39. CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.
López-Pacheco C; Soldevila G; Du Pont G; Hernández-Pando R; García-Zepeda EA
Mediators Inflamm; 2016; 2016():3635809. PubMed ID: 27795621
[TBL] [Abstract][Full Text] [Related]
40. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
Hieshima K; Kawasaki Y; Hanamoto H; Nakayama T; Nagakubo D; Kanamaru A; Yoshie O
J Immunol; 2004 Sep; 173(6):3668-75. PubMed ID: 15356112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
